Postprandial plasma PYY concentrations are associated with increased regional gray matter volume and rCBF declines in caudate nuclei - A combined MRI and H 2 15O PET study

NeuroImage

Volumn 60, Issue 1, 2012, Pages 592-600

  Weise, Christopher M ^a   Thiyyagura, Pradeep ^b   Reiman, Eric M ^b,c   Chen, Kewei ^b   Krakoff, Jonathan ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^b BANNER ALZHEIMER S INSTITUTE   (United States)

^c TRANSLATIONAL GENOMICS RESEARCH INSTITUTE   (United States)

Author keywords

Caudate nucleus; Gray matter; MRI; PET; PYY; RCBF; Striatum; VBM

Indexed keywords

GLUCOSE; INSULIN; OXYGEN 15; PEPTIDE YY; PEPTIDE YY [3-36];

ADULT; ANTERIOR CINGULATE; ARTICLE; BODY FAT; BRAIN BLOOD FLOW; BRAIN FUNCTION; CAUCASIAN; CAUDATE NUCLEUS; CEREBELLUM; CONTROLLED STUDY; DIET RESTRICTION; FEMALE; FUSIFORM GYRUS; GLOBUS PALLIDUS; GRAY MATTER; HIPPOCAMPUS; HORMONE BLOOD LEVEL; HUMAN; HUMAN EXPERIMENT; INFERIOR FRONTAL GYRUS; LIMBIC CORTEX; MALE; NORMAL HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; ORBITAL CORTEX; POSITRON EMISSION TOMOGRAPHY; POSTPRANDIAL STATE; PRIORITY JOURNAL; REGIONAL GRAY MATTER VOLUME; REGULATORY MECHANISM; VOXEL BASED MORPHOMETRY;

ADULT; CAUDATE NUCLEUS; CEREBROVASCULAR CIRCULATION; FEMALE; HUMANS; HYDROGEN; MAGNETIC RESONANCE IMAGING; MALE; ORGAN SIZE; OXYGEN RADIOISOTOPES; PEPTIDE YY; POSITRON-EMISSION TOMOGRAPHY; POSTPRANDIAL PERIOD; REGIONAL BLOOD FLOW;

EID: 84862809431     PISSN: 10538119     EISSN: 10959572     Source Type: Journal    
DOI: 10.1016/j.neuroimage.2011.12.023     Document Type: Article

References (68)

1. Abbott C.R., Small C.J., Kennedy A.R., Neary N.M., Sajedi A., Ghatei M.A., Bloom S.R. Blockade of the neuropeptide Y Y2 receptor with the specific antagonist BIIE0246 attenuates the effect of endogenous and exogenous peptide YY(3-36) on food intake. Brain Res. 2005, 1043(1-2):139-144.
2. Adewale A.S., Macarthur H., Westfall T.C. Neuropeptide Y induced modulation of dopamine synthesis in the striatum. Regul. Pept. 2005, 129(1-3):73-78.
3. Adrian T.E., Ferri G.L., Bacarese-Hamilton A.J., Fuessl H.S., Polak J.M., Bloom S.R. Human distribution and release of a putative new gut hormone, peptide YY. Gastroenterology 1985, 89(5):1070-1077.
4. Alexander G.E., Crutcher M.D., DeLong M.R. Basal ganglia-thalamocortical circuits: parallel substrates for motor, oculomotor, "prefrontal" and "limbic" functions. Prog. Brain Res. 1990, 85:119-146.
5. Ashburner J., Friston K.J. Voxel-based morphometry-the methods. NeuroImage 2000, 11(6 Pt 1):805-821.
6. Balleine B.W., Delgado M.R., Hikosaka O. The role of the dorsal striatum in reward and decision-making. J. Neurosci. 2007, 27(31):8161-8165.
7. Bartlett E.J., Brodie J.D., Simkowitz P., Dewey S.L., Rusinek H., Wolf A.P., Fowler J.S., Volkow N.D., Smith G., Wolkin A. Effects of haloperidol challenge on regional cerebral glucose utilization in normal human subjects. Am. J. Psychiatry 1994, 151(5):681-686.
8. Batterham R.L., Bloom S.R. The gut hormone peptide YY regulates appetite. Ann. N. Y. Acad. Sci. 2003, 994:162-168.
9. Batterham R.L., Cowley M.A., Small C.J., Herzog H., Cohen M.A., Dakin C.L., Wren A.M., Brynes A.E., Low M.J., Ghatei M.A., Cone R.D., Bloom S.R. Gut hormone PYY(3-36) physiologically inhibits food intake. Nature 2002, 418(6898):650-654.
10. Batterham R.L., Cohen M.A., Ellis S.M., Le Roux C.W., Withers D.J., Frost G.S., Ghatei M.A., Bloom S.R. Inhibition of food intake in obese subjects by peptide YY3-36. N. Engl. J. Med. 2003, 349(10):941-948.
11. Batterham R.L., ffytche D.H., Rosenthal J.M., Zelaya F.O., Barker G.J., Withers D.J., Williams S.C.R. PYY modulation of cortical and hypothalamic brain areas predicts feeding behaviour in humans. Nature 2007, 450(7166):106-109.
12. Berglund M.M., Hipskind P.A., Gehlert D.R. Recent developments in our understanding of the physiological role of PP-fold peptide receptor subtypes. Exp. Biol. Med. (Maywood) 2003, 228(3):217-244.
13. Bertolino A., Fazio L., Di Giorgio A., Blasi G., Romano R., Taurisano P., Caforio G., Sinibaldi L., Ursini G., Popolizio T., Tirotta E., Papp A., Dallapiccola B., Borrelli E., Sadee W. Genetically determined interaction between the dopamine transporter and the D2 receptor on prefronto-striatal activity and volume in humans. J. Neurosci. 2009, 29(4):1224-1234.
14. Bourdeau I., Bard C., Noël B., Leclerc I., Cordeau M.-P., Bélair M., Lesage J., Lafontaine L., Lacroix A. Loss of brain volume in endogenous Cushing's syndrome and its reversibility after correction of hypercortisolism. J. Clin. Endocrinol. Metab. 2002, 87(5):1949-1954.
15. Brogan A., Hevey D., Pignatti R. Anorexia, bulimia, and obesity: shared decision making deficits on the Iowa Gambling Task (IGT). J. Int. Neuropsychol. Soc. 2010, 16(4):711-715.
16. Brogan A., Hevey D., O'Callaghan G., Yoder R., O'Shea D. Impaired decision making among morbidly obese adults. J. Psychosom. Res. 2011, 70(2):189-196.
17. Cabrele C., Beck-Sickinger A.G. Molecular characterization of the ligand-receptor interaction of the neuropeptide Y family. J. Pept. Sci. 2000, 6(3):97-122.
18. Cox H.M. Peptide YY: a neuroendocrine neighbor of note. Peptides 2007, 28(2):345-351.
19. Degen L., Oesch S., Casanova M., Graf S., Ketterer S., Drewe J., Beglinger C. Effect of peptide YY3-36 on food intake in humans. Gastroenterology 2005, 129(5):1430-1436.
20. Ding L., Gold J.I. Caudate encodes multiple computations for perceptual decisions. J. Neurosci. 2010, 30(47):15747-15759.
21. Dumont Y., Fournier A., St-Pierre S., Quirion R. Characterization of neuropeptide Y binding sites in rat brain membrane preparations using [125I][Leu31, Pro34]peptide YY and [125I]peptide YY3-36 as selective Y1 and Y2 radioligands. J. Pharmacol. Exp. Ther. 1995, 272(2):673-680.
22. Fineberg N.A., Potenza M.N., Chamberlain S.R., Berlin H.A., Menzies L., Bechara A., Sahakian B.J., Robbins T.W., Bullmore E.T., Hollander E. Probing compulsive and impulsive behaviors, from animal models to endophenotypes: a narrative review. Neuropsychopharmacology 2010, 35(3):591-604.
23. Friston K.J., Frith C.D., Frackowiak R.S., Turner R. Characterizing dynamic brain responses with fMRI: a multivariate approach. NeuroImage 1995, 2(2):166-172.
24. Gaser C. Partial volume segmentation with adaptive maximum a posteriori (MAP) approach. NeuroImage 2009, 47:S121.
25. Gehlert D.R. Multiple receptors for the pancreatic polypeptide (PP-fold) family: physiological implications. Proc. Soc. Exp. Biol. Med. 1998, 218(1):7-22.
26. Ghitza U.E., Nair S.G., Golden S.A., Gray S.M., Uejima J.L., Bossert J.M., Shaham Y. Peptide YY3-36 decreases reinstatement of high-fat food seeking during dieting in a rat relapse model. J. Neurosci. 2007, 27(43):11522-11532.
27. Green E., Jacobson A., Haase L., Murphy C. Reduced nucleus accumbens and caudate nucleus activation to a pleasant taste is associated with obesity in older adults. Brain Res. 2011, 1386:109-117.
28. Guh D.P., Zhang W., Bansback N., Amarsi Z., Birmingham C.L., Anis A.H. The incidence of co-morbidities related to obesity and overweight: a systematic review and meta-analysis. BMC Publ. Health 2009, 9:88.
29. Haber S.N., Kim K.-S., Mailly P., Calzavara R. Reward-related cortical inputs define a large striatal region in primates that interface with associative cortical connections, providing a substrate for incentive-based learning. J. Neurosci. 2006, 26(32):8368-8376.
30. Haruno M., Kuroda T., Doya K., Toyama K., Kimura M., Samejima K., Imamizu H., Kawato M. A neural correlate of reward-based behavioral learning in caudate nucleus: a functional magnetic resonance imaging study of a stochastic decision task. J. Neurosci. 2004, 24(7):1660-1665.
31. Hershey T., Black K.J., Stambuk M.K., Carl J.L., McGee-Minnich L.A., Perlmutter J.S. Altered thalamic response to levodopa in Parkinson's patients with dopa-induced dyskinesias. Proc. Natl. Acad. Sci. U. S. A. 1998, 95(20):12016-12021.
32. Hershey T., Black K.J., Carl J.L., Perlmutter J.S. Dopa-induced blood flow responses in nonhuman primates. Exp. Neurol. 2000, 166(2):342-349.
33. Hnasko T.S., Szczypka M.S., Alaynick W.A., During M.J., Palmiter R.D. A role for dopamine in feeding responses produced by orexigenic agents. Brain Res. 2004, 1023(2):309-318.
34. Hong M., Li S., Pelletier G. Role of neuropeptide Y in the regulation of tyrosine hydroxylase messenger ribonucleic acid levels in the male rat arcuate nucleus as evaluated by in situ hybridization. J. Neuroendocrinol. 1995, 7(1):25-28.
35. Hostetler E.D., Sanabria-Bohórquez S., Fan H., Zeng Z., Gantert L., Williams M., Miller P., O'Malley S., Kameda M., Ando M., Sato N., Ozaki S., Tokita S., Ohta H., Williams D., Sur C., Cook J.J., Burns H.D., Hargreaves R. Synthesis, characterization, and monkey positron emission tomography (PET) studies of [18F]Y1-973, a PET tracer for the neuropeptide Y Y1 receptor. NeuroImage 2011, 54(4):2635-2642.
36. Keire D.A., Mannon P., Kobayashi M., Walsh J.H., Solomon T.E., Reeve J.R. Primary structures of PYY, [Pro(34)]PYY, and PYY-(3-36) confer different conformations and receptor selectivity. Am. J. Physiol. Gastrointest. Liver Physiol. 2000, 279(1):G126-G131.
37. Koob G.F., Volkow N.D. Neurocircuitry of addiction. Neuropsychopharmacology 2010, 35(1):217-238.
38. Kringelbach M.L., Rolls E.T. The functional neuroanatomy of the human orbitofrontal cortex: evidence from neuroimaging and neuropsychology. Prog. Neurobiol. 2004, 72(5):341-372.
39. Lahti A.C., Holcomb H.H., Weiler M.A., Medoff D.R., Tamminga C.A. Functional effects of antipsychotic drugs: comparing clozapine with haloperidol. Biol. Psychiatry 2003, 53(7):601-608.
40. Lahti A.C., Weiler M.A., Medoff D.R., Tamminga C.A., Holcomb H.H. Functional effects of single dose first- and second-generation antipsychotic administration in subjects with schizophrenia. Psychiatry Res. 2005, 139(1):19-30.
41. Lancaster J.L., Woldorff M.G., Parsons L.M., Liotti M., Freitas C.S., Rainey L., Kochunov P.V., Nickerson D., Mikiten S.A., Fox P.T. Automated Talairach atlas labels for functional brain mapping. Hum. Brain Mapp. 2000, 10(3):120-131.
42. le Roux C.W., Batterham R.L., Aylwin S.J.B., Patterson M., Borg C.M., Wynne K.J., Kent A., Vincent R.P., Gardiner J., Ghatei M.A., Bloom S.R. Attenuated peptide YY release in obese subjects is associated with reduced satiety. Endocrinology 2006, 147(1):3-8.
43. Liu X., Hairston J., Schrier M., Fan J. Common and distinct networks underlying reward valence and processing stages: a meta-analysis of functional neuroimaging studies. Neurosci. Biobehav. Rev. 2011, 35(5):1219-1236.
44. Maldjian J.A., Laurienti P.J., Kraft R.A., Burdette J.H. An automated method for neuroanatomic and cytoarchitectonic atlas-based interrogation of fMRI data sets. NeuroImage 2003, 19(3):1233-1239.
45. Matochik J.A., London E.D., Yildiz B.O., Ozata M., Caglayan S., DePaoli A.M., Wong M.-L., Licinio J. Effect of leptin replacement on brain structure in genetically leptin-deficient adults. J. Clin. Endocrinol. Metab. 2005, 90(5):2851-2854.
46. Meguid M.M., Glade M.J., Middleton F.A. Weight regain after Roux-en-Y: a significant 20% complication related to PYY. Nutrition 2008, 24(9):832-842.
47. Mentlein R., Dahms P., Grandt D., Krüger R. Proteolytic processing of neuropeptide Y and peptide YY by dipeptidyl peptidase IV. Regul. Pept. 1993, 49(2):133-144.
48. Michel M.C., Beck-Sickinger A., Cox H., Doods H.N., Herzog H., Larhammar D., Quirion R., Schwartz T., Westfall T. XVI. International Union of Pharmacology recommendations for the nomenclature of neuropeptide Y, peptide YY, and pancreatic polypeptide receptors. Pharmacol. Rev. 1998, 50(1):143-150.
49. Neary M.T., Batterham R.L. Gaining new insights into food reward with functional neuroimaging. Forum Nutr. 2010, 63:152-163.
50. Nieoullon A. Dopamine and the regulation of cognition and attention. Prog. Neurobiol. 2002, 67(1):53-83.
51. Oberndorfer T.A., Kaye W.H., Simmons A.N., Strigo I.A., Matthews S.C. Demand-specific alteration of medial prefrontal cortex response during an inhibition task in recovered anorexic women. Int. J. Eat. Disord. 2011, 44(1):1-8.
52. Pannacciulli N., Le D.S.N.T., Chen K., Reiman E.M., Krakoff J. Relationships between plasma leptin concentrations and human brain structure: a voxel-based morphometric study. Neurosci. Lett. 2007, 412(3):248-253.
53. Parker R.M., Herzog H. Regional distribution of Y-receptor subtype mRNAs in rat brain. Eur. J. Neurosci. 1999, 11(4):1431-1448.
54. Perry J.L., Joseph J.E., Jiang Y., Zimmerman R.S., Kelly T.H., Darna M., Huettl P., Dwoskin L.P., Bardo M.T. Prefrontal cortex and drug abuse vulnerability: translation to prevention and treatment interventions. Brain Res. Rev. 2011, 65(2):124-149.
55. Pfluger P.T., Kampe J., Castaneda T.R., Vahl T., D'Alessio D.A., Kruthaupt T., Benoit S.C., Cuntz U., Rochlitz H.J., Moehlig M., Pfeiffer A.F.H., Koebnick C., Weickert M.O., Otto B., Spranger J., Tschöp M.H. Effect of human body weight changes on circulating levels of peptide YY and peptide YY3-36. J. Clin. Endocrinol. Metab. 2007, 92(2):583-588.
56. Raben A., Tagliabue A., Astrup A. The reproducibility of subjective appetite scores. Br. J. Nutr. 1995, 73(4):517-530.
57. Ren J., Xu H., Choi J.-K., Jenkins B.G., Chen Y.I. Dopaminergic response to graded dopamine concentration elicited by four amphetamine doses. Synapse 2009, 63(9):764-772.
58. Sloth B., Holst J.J., Flint A., Gregersen N.T., Astrup A. Effects of PYY1-36 and PYY3-36 on appetite, energy intake, energy expenditure, glucose and fat metabolism in obese and lean subjects. Am. J. Physiol. Endocrinol. Metab. 2007, 292(4):E1062-E1068.
59. Spitzer R.L., Williams J.B., Gibbon M., First M.B. Structured Clinical Interview for DSM-III-R, Patient Edition/Non-patient Edition, (SCID-P/SCID-NP) 1990, American Psychiatric Press, Inc., Washington, D.C.
60. Starkman M.N., Giordani B., Gebarski S.S., Berent S., Schork M.A., Schteingart D.E. Decrease in cortisol reverses human hippocampal atrophy following treatment of Cushing's disease. Biol. Psychiatry 1999, 46(12):1595-1602.
61. Stice E., Spoor S., Bohon C., Veldhuizen M., Small D. Relation of reward from food intake and anticipated food intake to obesity: a functional magnetic resonance imaging study. J. Abnorm. Psychol. 2008, 117(4):924-935.
62. Tataranni P.A., Gautier J.F., Chen K., Uecker A., Bandy D., Salbe A.D., Pratley R.E., Lawson M., Reiman E.M., Ravussin E. Neuroanatomical correlates of hunger and satiation in humans using positron emission tomography. Proc. Natl. Acad. Sci. U. S. A. 1999, 96(8):4569-4574.
63. Tripp G., Wickens J.R. Neurobiology of ADHD. Neuropharmacology 2009, 57(7-8):579-589.
64. Tzourio-Mazoyer N., Landeau B., Papathanassiou D., Crivello F., Etard O., Delcroix N., Mazoyer B., Joliot M. Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain. NeuroImage 2002, 15(1):273-289.
65. Volkow N.D., Wang G.J., Telang F., Fowler J.S., Goldstein R.Z., Alia-Klein N., Logan J., Wong C., Thanos P.K., Ma Y., et al. Inverse association between BMI and prefrontal metabolic activity in healthy adults. Obesity 2008, 17(1):60-65.
66. Volkow N.D., Wang G.-J., Telang F., Fowler J.S., Thanos P.K., Logan J., Alexoff D., Ding Y.-S., Wong C., Ma Y., Pradhan K. Low dopamine striatal D2 receptors are associated with prefrontal metabolism in obese subjects: possible contributing factors. NeuroImage 2008, 42(4):1537-1543.
67. Widdowson P.S. Quantitative receptor autoradiography demonstrates a differential distribution of neuropeptide-Y Y1 and Y2 receptor subtypes in human and rat brain. Brain Res. 1993, 631(1):27-38.
68. Witte A.-B., Grybäck P., Holst J.J., Hilsted L., Hellström P.M., Jacobsson H., Schmidt P.T. Differential effect of PYY1-36 and PYY3-36 on gastric emptying in man. Regul. Pept. 2009, 158(1-3):57-62.